Defensive · 34 dossiers

AI point-of-care ultrasound narrative accelerating: Q1 2026 revenue +25% YoY ($26.5M), Butterfly Embedded chip-licensing +147%, first FDA-cleared blind-sweep AI tool, Compass AI and HomeCare commercializing through 2026. But the CBO sold…

Mastercard USDC settlement catalyst (6/03) printed and is being faded the same release added Ripple's RLUSD, commoditizing the 'only rail' thesis. Theme model flipped SATURATED (6/05) and Mizuho cut its PT to $85 the next day. A…

Optimus/Robotaxi leg is contested and maturing, not accelerating. Robotaxi fleet shrank to 20 cars (6/4), Roadster demo slipped to August (6/5), and NVIDIA's open robotics platform plus Sam Altman are arming/attacking the humanoid moat.…

Crypto-financials leg that ran on BTC>$80k has rolled over for GLXY specifically: a 265.1M-share registration (5/21) is a multi-week supply overhang, a $100M BitGo claim (5/21) adds legal risk, and CEO Novogratz flagged a market top…

Rare-earths ACCEL (0.50), gov-equity meta-theme widening (drones/quantum/AI labs) with MP the DoD prototype; 2 insider buys (rule 9). But sell-side only just initiated (late-cycle) and RECENTLY_EXITED -6% twice LOW probe.

Hyperliquid proxy with a fresh institutional narrative leg (ICE CEO "bigger than Nasdaq" 5/29; Hayes $100k bet 6/2), but the crypto tape just broke BTC/ETH/SOL all -10%+ in a week into 6/4, BTC sub-$68k. A 35.16M-share secondary overhangs…

WTI crude is in a war-premium regime (~$92, Hormuz shut since March), yet W&T Offshore trades $4.11 near 52-week lows a Gulf producer that can't rally on its perfect macro because Q1 hedges booked a $24.5M derivative loss. The June 12…

Edge-AI silicon small-cap. Q1 blowout + Q2 guide-raise (2026-05-12) drove a parabolic to $85.77 ATH (May 26); June 5 -12.4% distribution day is the first crack. Catalyst already fired, now trades above analyst PTs ($70), no catalyst until…

Cyclical electrical-products inflection (first net-sales growth since FY2022, Q2 reported 5/5) ran to a fresh 52w high $90.16 — then FAILED back to $80.61 (-5.1% on 6/5) as the May jobs report pushed the 30Y >5% and gutted the rate…

Driverless-freight commercialization is real (McLane/Berkshire live in TX May 6, Volvo Dallas–OKC route, 7 customers, 200-truck year-end target) but the early-May momentum leg has rolled over ~26% from the $8.50 May-14 high to ~$6.3…

TAVR disruptor at fresh 52w-high but on momentum not news, into a live $250M ATM seller, real binary ~2028 idiosyncratic, MATURING.

Drive-thru coffee unit-growth story re-accelerating on mobile order-ahead + a hot-food daypart Q1 systemwide comps +8.3% and FY26 guidance raised (2026-05-06). But the tape is parabolic into RSI ~83 and founder Boersma sold ~$92.5M into…

Binary Q1 catalyst is spent. The 2026-06-04 print beat (adj EPS $0.38 vs $0.31, sales +8.5% to $667M) but the stock rose only +0.64% after a +14% run-in the beat was fully priced. Brand-Portfolio re-rate is real yet Famous Footwear still…

Auto-insurance ad-spend recovery has matured Q1'26 rev +15% to $190.9M, third straight quarter plateaued ~$190M. Post-earnings bounce ran +36% over 4 weeks to ~$20 — but stalled under the 200-DMA ~$22.49 and is now fading. No accelerating…

Space-defense mania ran parabolic into the 6/12 SpaceX IPO; FLY then gave back ~25% from its $48 May secondary to ~$36 on dilution (12M-sh offering + 11.11M resale registration) and IPO fatigue (RDW/MNTS -20%). Business is accelerating Q1…

Post-earnings momentum leg has fully rolled over: LIFE broke the ~$17.50 consolidation floor (closed $16.82, 2026-06-05) as Bear Cave's upfront-accounting short thesis takes control and a June-16/July-27 lock-up supply cascade lands.…

Yield-led freight-recovery narrative maturing into all-time highs: May revenue/day +12.3% is fuel and pricing rather than volume (LTL tons still -3.8%). Amazon's June 10 full-LTL launch gapped ODFL -7.2%, and consensus targets (~$210) sit…

Merger-arb instrument (SWKS $32.50 + 0.96sh), upside capped at deal value, downside binary on a SAMR break the 52w-high/RSI signals are SWKS artifacts, outside the momentum edge.

Implantable-CGM ADA-de-risked but fell INTO its catalyst (below 50-day, supply>demand), micro-cap value-trap DXCM is the cluster pick.

Oral-GPCR platform story accelerating: Novo Nordisk obesity deal funds 5 targets, SEP-631 printed positive CSU Phase 1, and SEP-479 hits the ENDO 2026 stage this week. But it's a 3x into all-time highs (~$32) and the ENDO slot is…

April narrative-momentum breakout fully round-tripped: denifanstat's retail spike faded and SGMT sits at $6.76 (2026-06-05), barely above its $6.00 April offering price after the float nearly doubled to 61.75M shares. Dermatology pivot +…

Real new growth leg Smith+Nephew pelvic-trauma distribution plus a raised FY guide ($230–233M) on a profit-inflecting SI-fusion base but the tape is broken: ~$15.50 sits below the 200-day, 50<200, ~29% off highs. Cheap medtech on a…

Early-cycle freight-rate recovery has re-rated SNDR from ~$20 to 52-week highs near $39, but the move front-runs an earnings inflection Q1 ($0.12 adj EPS, ops income -21% YoY) hasn't delivered. Sell-side PTs ($36–$39) now sit on the price…

Space-satellite theme ACCELERATING into the SpaceX-IPO proxy frenzy (UFO ETF crossed $1B AUM 2026-05-28); SPIR rides cluster beta on a clean Q1 beat + raised FY26 guide (05-13) and a rising PT ladder (Stifel $24, 06-04). But it's the…

Busted-IPO thrift retailer basing on a trade-down narrative: Q1 (rep. ~2026-05-06) net sales +8.9%, U.S. comps +6.4%, and a 2026-06-02 term-loan rate cut sparked a +14.9% 30-day move off lows toward $13–14 analyst targets. But it's a…

Analog ACCELERATING tag but ZERO AI/HBM exposure (auto-cycle), post-catalyst momentum chase, broken quote prior session APH is the cleaner analog pick.